Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Top Cited Papers
Open Access
- 1 April 2015
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 27 (4), 574-588
- https://doi.org/10.1016/j.ccell.2015.03.008
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated MelanomaThe New England Journal of Medicine, 2014
- The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAFCancer Research, 2014
- A tense situation: forcing tumour progressionNature Reviews Cancer, 2009
- A genetically encoded fluorescent sensor of ERK activityProceedings of the National Academy of Sciences of the United States of America, 2008
- Detection of Mutations inEGFRin Circulating Lung-Cancer CellsThe New England Journal of Medicine, 2008
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological TargetingPLoS Medicine, 2008
- A global double‐fluorescent Cre reporter mousegenesis, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaThe New England Journal of Medicine, 2006
- Presence ofEpidermal Growth Factor ReceptorGene T790M Mutation as a Minor Clone in Non–Small Cell Lung CancerCancer Research, 2006
- Fibroblasts in cancerNature Reviews Cancer, 2006